Demant A/S: Financial calendar 2023
|
Company announcement no 2022-14 |
9 December 2022 |
Financial calendar 2023
|
24 January |
Deadline for submission of items for the agenda of the annual |
|
17 January to 6 February
|
Quiet period prior to publication of Annual Report 2022 |
|
7 February
|
Annual Report 2022 |
|
8 March
|
Annual general meeting |
|
12 April to 2 May
|
Quiet period prior to publication of Interim Management Statement |
|
3 May
|
Interim Management Statement |
|
26 July to 15 August
|
Quiet period prior to publication of Interim Report 2023 |
|
16 August
|
Interim Report 2023 |
|
17 October to 6 November
|
Quiet period prior to publication of Interim Management Statement |
|
7 November
|
Interim Management Statement |
* Please note that if a shareholder would like to have a specific item included in the agenda for the annual general meeting on 8 March 2023, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 24 January 2023.
|
Further information: Peter Pudselykke, Investor Relations Officer Phone +45 3917 7300 |
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Alternative languages
Attachments
Subscribe to our company announcements
Keep up to date with our company announcements by subscribing.
Visit our pressroom and see more company announcements from us.
Our pressroom